Skip to main content

and
  1. Article

    Open Access

    Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study

    To evaluate immune responses to COVID-19 vaccines in adults aged 50 years and older, spike protein (S)-specific antibody concentration, avidity, and function (via angiotensin-converting enzyme 2 (ACE2) inhibit...

    Gabrielle N. Gaultier, Brynn McMillan, Chad Poloni, Mandy Lo in Scientific Reports (2024)

  2. Article

    Open Access

    Factors associated with SARS-CoV-2 infection in unvaccinated children and young adults

    Pediatric COVID-19 cases are often mild or asymptomatic, which has complicated estimations of disease burden using existing testing practices. We aimed to determine the age-specific population seropositivity a...

    Sarah L. Silverberg, Hennady P. Shulha, Brynn McMillan in BMC Infectious Diseases (2024)

  3. Article

    Open Access

    Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada

    We sought to evaluate the rates and predictors of SARS-CoV-2 vaccination among members of a structurally-marginalized population of people who use drugs (PWUD) during a targeted, community-wide, vaccination ca...

    Hudson Reddon, Brittany Barker, Sofia Bartlett, Ana Citlali Márquez in Scientific Reports (2023)

  4. Article

    Open Access

    Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis

    Epstein-Barr virus (EBV) has been identified as a putative environmental trigger of multiple sclerosis (MS) by multiple groups working worldwide. Previously, we reported that when experimental autoimmune encep...

    Costanza Casiraghi, Ana Citlali Márquez, Iryna Shanina in Scientific Reports (2015)